Obesity & GLP-1 ETFs
SLIM — Tema Cardiovascular and Metabolic ETF
Tema · Active (cardiometabolic) · since 2023
Cardiometabolic health more broadly: obesity, diabetes and heart disease treatment.
- Expense ratio
- 0.75%
- AUM
- $30M
- Dividend yield
- 0.7%
- 1Y return
- +11.1%
- 3Y ann.
- —
- 5Y ann.
- —
- 10Y ann.
- —
- All-time ann.
- —
Top holdings
- Eli Lilly9.40%
- Novo Nordisk8.10%
- Boston Scientific6.40%
- Medtronic5.10%
- Edwards Lifesciences4.60%
35 total holdings · 45.0% in the top 10